AU Patent

AU2019200138B2 — Sublingual films

Assigned to Sumitomo Pharma America Inc · Expires 2021-01-14 · 5y expired

What this patent protects

The invention features sublingual film formulations of dopamine agonists and methods of treating Parkinson's disease, tremors, restless leg syndrome, sexual dysfunction, and depressive disorders therewith.

USPTO Abstract

The invention features sublingual film formulations of dopamine agonists and methods of treating Parkinson's disease, tremors, restless leg syndrome, sexual dysfunction, and depressive disorders therewith.

Drugs covered by this patent

Patent Metadata

Patent number
AU2019200138B2
Jurisdiction
AU
Classification
—
Expires
2021-01-14
Drug substance claim
No
Drug product claim
No
Assignee
Sumitomo Pharma America Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.